CoC Quality Measure Development

The Quality Integration Committee (QIC) of the Commission on Cancer (CoC) partners with internal and external clinical experts to develop quality measures. The development and approval of quality measures encompassing multiple primary sites relies on the specialized expertise of members of the QIC and CoC Member Organizations. The currently reported gynecologic measures were developed in the conjunction with the Society of Gynecologic Oncology (SGO). Additionally, the QIC is collaborating with experts from the Society of Surgical Oncology (SSO) and the Society of Urologic Oncology (SUO)/American Urologic Association (AUA) on quality measures.

There are several types of measures approved by the CoC. Evidence-based measures or accountability measures promote improvements in care delivery and are the highest standard for measurement. These measures demonstrate provider accountability, influence payment for services, and promote transparency. The quality improvement measure function is to monitor the need for quality improvement or remediation. Generally, these measures are for individual program use. Surveillance measures are used to identify the status quo, generate information for decision making, and/or to monitor patterns and trends of care. The following table summarizes the purposes and use of these measures:

For questions related to the release of these quality measures, please contact the NCDB at ncdb@facs.org.